KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 3 filers reported holding KARUNA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 3.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,842,063 | -64.6% | 22,722 | -54.6% | 0.04% | -65.1% |
| Q2 2023 | $10,864,185 | +231.1% | 50,100 | +243.5% | 0.13% | +180.4% |
| Q3 2022 | $3,281,000 | -82.3% | 14,585 | -90.1% | 0.05% | -83.9% |
| Q2 2022 | $18,563,000 | +70.3% | 146,735 | +70.6% | 0.29% | +61.6% |
| Q1 2022 | $10,903,000 | +396.5% | 85,990 | +412.9% | 0.18% | +471.0% |
| Q4 2021 | $2,196,000 | +68.3% | 16,764 | +57.1% | 0.03% | +47.6% |
| Q3 2021 | $1,305,000 | +7.3% | 10,668 | 0.0% | 0.02% | -8.7% |
| Q2 2021 | $1,216,000 | -5.2% | 10,668 | 0.0% | 0.02% | -17.9% |
| Q1 2021 | $1,283,000 | – | 10,668 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |